Antiviral Drugs
Information for Health Care Professionals
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza – Recommendations of the Advisory Committee on Immunization Practices (ACIP) PDF [1 MB, 28 pages]
Additional Information for Health Care Professionals
CDC Expert Commentary on Medscape: 2016-2017 Influenza Antiviral Recommendations
CDC Expert Commentary on Medscape: High-Risk Patient With Possible Flu? Start Those Antivirals (Video, password required) April 20, 2015
Medical Office Telephone Evaluation of Patients with Possible Influenza January 27, 2015
CDC Health Update Regarding Treatment of Patients with Influenza with Antiviral Medications Distributed via the CDC Health Alert Network, January 9, 2015, 11:00 ET, CDCHAN-00375
FDA approves Rapivab to treat flu infection December 22, 2014
CDC Health Advisory Regarding the Potential for Circulation of Drifted Influenza A (H3N2) Viruses . Distributed via the CDC Health Alert Network, December 3, 2014, 16:00 ET (4:00PM ET), CDCHAN-00374
Have You Heard: CDC Recommendations for Influenza Antiviral Medications Remain Unchanged April 10, 2014
Clinician Misperceptions Related to Influenza Testing and Treatment January 23, 2014
Flu Spotlight: CDC Research Confirms Benefits of Flu Antiviral Drugs, Even Beyond 2 Days After Symptoms Start November 22, 2013
FDA expands Tamiflu’s use to treat children younger than 1 year December 21, 2012
Have You Heard: CDC Influenza Antiviral Statement February 7, 2012
Information for the Public
